Skip to content

Clinical trials

Withdrawn Phase 1 Central Nervous System Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Central Nervous System Neoplasms Phase: Phase 1 Status: Withdrawn Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20081
20101
20141
20191
20211
20221
20242
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Withdrawn10

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
M.D. Anderson Cancer Center2
Children's Oncology Group1
Jeffrey Treiber1
Mayo Clinic1
National Cancer Institute (NCI)1
Northwestern University1
St. Jude Children's Research Hospital1
SynerGene Therapeutics, Inc.1
West Virginia University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Central Nervous System Neoplasms10
Lymphoma3
Medulloblastoma3
Ependymoma2
Astrocytoma1
Brain Neoplasms1
Breast Neoplasms1
Burkitt Lymphoma1
Choroid Plexus Neoplasms1
Colorectal Neoplasms, Hereditary Nonpolyposis1

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.